Business
ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The CE Mark certification allows marketing for both clinic and home useFirst commercial sales of the ARC-EX® System in Europe are expected in Q4 2025The CE Mark enables commercialization in the European Union and facilitates a streamlined regulatory pathway in other countries, including in the UK and Switzerland EINDHOVEN, the Netherlands, Sept. 08, 2025 (GLOBE NEW
About this update from Onward Medical N.v.
[{"type":"image","alt":"ONWARD Medical NV","displaySize":"","headline":null,"caption":"ONWARD Medical NV","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":150,"url":"https://media.zenfs.com/en/globenewswire.com/ff435d5a4437f6b633ad80dab68096d0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/CPLGUw1yVOurWsVIgzW3oQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ff435d5a4437f6b633ad80dab68096d0","width":300,"height":150}},"lazy":false},{"type":"text","content":"THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)","length":132,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"The CE Mark certification allows marketing for both clinic and home use","length":71,"tagName":"p"}]},{"val":[{"type":"text","content":"First commercial sales of the ARC-EX® System in Europe are expected in Q4 2025","length":78,"tagName":"p"}]},{"val":[{"type":"text","content":"The CE Mark enables commercialization in the European Union and facilitates a streamlined regulatory pathway in other countries, including in the UK and Switzerland","length":164,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":313,"olType":false},{"type":"text","content":"EINDHOVEN, the Netherlands, Sept. 08, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today announced it has received CE Mark certification for its ARC-EX System under the European Union Medical Device Regulation (MDR), enabling commercialization in the European Union and certain other countries.","length":513,"tagName":"p"},{"type":"text","content":"This certification enables the Company to promote the use of the ARC-EX System in conjunction with functional task practice to improve hand strength and sensation in adults with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive). The certification allows marketing for both clinic and home use. The ARC-EX System is non-invasive and delivers programmed, transcutaneous electrical spinal cord stimulation via electrodes placed ...